SALES FORECAST: The Swiss pharma giant's third-quarter sales are forecast at 14.89 billion Swiss francs ($17.22 billion), according to a consensus of 11 analysts' estimates compiled by Visible Alpha.

U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG (RHHVF – Research ...

Goldman Sachs first debuted the GRANOLAS acronym - standing for GSK (GSK), Roche, ASML (ASML), Nestle, Novartis (NVS), Novo Nordisk (NVO), L'Oreal, LVMH, AstraZeneca (AZN), SAP (SAP) and Sanofi (SNY) ...

Cathie Wood, the CEO of Ark Invest, has several AI stocks in her investment management firm's actively managed ETFs. One of ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

Pfizer Inc.’s Hympavzi won US approval to treat hemophilia, a potentially deadly genetic disorder that prevents blood from clotting properly.

PDUFA date, the U.S. FDA has approved Genentech Inc.’s first-line breast cancer treatment Itovebi (inavolisib). Itovebi is to be combined with Pfizer Inc.’s palbociclib (Ibrance) and fulvestrant for ...

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

It feels like a curse! However, plenty of Amazon shoppers are in the same boat, and thousands (60,000 to be exact) say the La Roche-Posay Toleriane Double Repair Face Moisturizer is the only thing ...